Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-027521
Filing Date
2025-03-25
Accepted
2025-03-25 07:00:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2510082-1_424b5.htm 424B5 672154
2 GRAPHIC lg_transcodetheraptm-4c.jpg GRAPHIC 10109
  Complete submission text file 0001104659-25-027521.txt   687258
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-268764 | Film No.: 25765801
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)